Search results for "Constipation"


 
Results 1 - 10 of about 22 for "Constipation".

MKSAP quiz: Persistent constipation for 2 years | ACP Gastroenterology Monthly

This month's quiz asks readers to determine the most appropriate treatment for persistent constipation in a 60-year-old woman taking chronic opioid analgesic therapy for reflex sympathetic dystrophy syndrome.

Drug for chronic idiopathic constipation approved | ACP Gastroenterology Monthly

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.

MKSAP quiz: Long-term refractory constipation | ACP Gastroenterology Monthly

This month's quiz asks readers to determine the most appropriate management for a 36-year-old woman with a 12-year history of refractory constipation that began after a difficult childbirth.

Mu-opioid receptor antagonists appear safe, effective for opioid-induced constipation, review finds | ACP Gastroenterology Monthly

Researchers looked at randomized controlled trials of peripheral mu-opioid receptor antagonists (methylnaltrexone, naloxone, naloxegol, alvimopan, axelopran, or naldemedine) and the prescription-strength laxatives lubiprostone or prucalopride.

AGA issues guideline on opioid-induced constipation | ACP Gastroenterology Monthly

Opioid-induced constipation differs mechanistically from other forms of the disorder, and its medical management deserves dedicated attention, the American Gastroenterological Association (AGA) said.

Drug options available for opioid-induced constipation | ACP Gastroenterology Monthly

Four FDA-approved drugs for opioid-induced constipation form the backbone of treatment, with more options in the research pipeline.

Naloxone, naldemedine appear best for opioid-induced constipation after laxatives | ACP Gastroenterology Monthly

A meta-analysis found naloxone to have the highest efficacy and safety of pharmacological therapies for opioid-induced constipation, and previous research has shown it to be cost-effective, study authors said.

In IBS with constipation, plecanatide reduced abdominal pain and increased bowel movements at 12 wk | ACP Gastroenterology Monthly

Clinical judgment will be needed to determine whether the relatively modest improvement in outcomes will be important to patients for whom the drug is considered, according to an accompanying ACP Journal Club commentary.

In chronic severe functional constipation, electroacupuncture increased complete spontaneous bowel movements | ACP Gastroenterology Monthly

Patients undergoing electroacupuncture experienced a change from baseline in mean complete spontaneous bowel movements per week during the treatment period, and treatment effects were even greater after patients stopped attending the sessions.

Recent conference coverage featured gastroenterology and hepatology topics | ACP Gastroenterology Monthly

Conference coverage in the December ACP Hospitalist addressed acute-on-chronic liver failure and inpatient constipation.

Result Page: Prev   1   2   3   Next